The cost and challenge of vaccine development for emerging and emergent infectious diseases

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{e6175eff133543c18aaf859ad2fe3529,

title = "The cost and challenge of vaccine development for emerging and emergent infectious diseases",

author = "Maslow, {Joel N.}",

year = "2018",

month = dec,

doi = "10.1016/S2214-109X(18)30418-2",

language = "English (US)",

volume = "6",

pages = "e1266--e1267",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "Elsevier BV",

number = "12",

}

TY - JOUR

T1 - The cost and challenge of vaccine development for emerging and emergent infectious diseases

AU - Maslow, Joel N.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85056314862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056314862&partnerID=8YFLogxK

U2 - 10.1016/S2214-109X(18)30418-2

DO - 10.1016/S2214-109X(18)30418-2

M3 - Comment/debate

C2 - 30342926

AN - SCOPUS:85056314862

SN - 2214-109X

VL - 6

SP - e1266-e1267

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 12

ER -